Praxis Precision Medicines Inc. (PRAX): Price and Financial Metrics
PRAX Price/Volume Stats
| Current price | $42.34 | 52-week high | $91.83 |
| Prev. close | $42.97 | 52-week low | $26.70 |
| Day low | $41.87 | Volume | 400,000 |
| Day high | $43.27 | Avg. volume | 447,899 |
| 50-day MA | $38.08 | Dividend yield | N/A |
| 200-day MA | $58.26 | Market Cap | 862.42M |
PRAX Stock Price Chart Interactive Chart >
Praxis Precision Medicines Inc. (PRAX) Company Bio
Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.
PRAX Price Returns
| 1-mo | 12.76% |
| 3-mo | 12.28% |
| 6-mo | -45.19% |
| 1-year | 1.53% |
| 3-year | 20.63% |
| 5-year | N/A |
| YTD | -44.98% |
| 2024 | 245.42% |
| 2023 | -37.59% |
| 2022 | -87.92% |
| 2021 | -64.19% |
| 2020 | N/A |
Loading social stream, please wait...